Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Meglumine Antimoniate
1.2.3 Pentamidine
1.2.4 Hydroxyl Amidine Stilbene
1.2.5 Amphotericin B
1.3 Market by Application
1.3.1 Global Leishmaniasis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Visceral Leishmaniasis
1.3.3 Cutaneous Leishmaniasis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leishmaniasis Treatment Market Perspective (2018-2033)
2.2 Leishmaniasis Treatment Growth Trends by Region
2.2.1 Global Leishmaniasis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Leishmaniasis Treatment Market Dynamics
2.3.1 Leishmaniasis Treatment Industry Trends
2.3.2 Leishmaniasis Treatment Market Drivers
2.3.3 Leishmaniasis Treatment Market Challenges
2.3.4 Leishmaniasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leishmaniasis Treatment Players by Revenue
3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2018-2023)
3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
3.4 Global Leishmaniasis Treatment Market Concentration Ratio
3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2022
3.5 Leishmaniasis Treatment Key Players Head office and Area Served
3.6 Key Players Leishmaniasis Treatment Product Solution and Service
3.7 Date of Enter into Leishmaniasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leishmaniasis Treatment Breakdown Data by Type
4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2024-2033)
5 Leishmaniasis Treatment Breakdown Data by Application
5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Leishmaniasis Treatment Market Size (2018-2033)
6.2 North America Leishmaniasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Leishmaniasis Treatment Market Size by Country (2018-2023)
6.4 North America Leishmaniasis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leishmaniasis Treatment Market Size (2018-2033)
7.2 Europe Leishmaniasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Leishmaniasis Treatment Market Size by Country (2018-2023)
7.4 Europe Leishmaniasis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Leishmaniasis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leishmaniasis Treatment Market Size (2018-2033)
9.2 Latin America Leishmaniasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Leishmaniasis Treatment Market Size by Country (2018-2023)
9.4 Latin America Leishmaniasis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Leishmaniasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Leishmaniasis Treatment Introduction
11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2018-2023)
11.1.5 Merck Recent Development
11.2 iCo Therapeutics
11.2.1 iCo Therapeutics Company Detail
11.2.2 iCo Therapeutics Business Overview
11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2018-2023)
11.2.5 iCo Therapeutics Recent Development
11.3 AEterna Zentaris
11.3.1 AEterna Zentaris Company Detail
11.3.2 AEterna Zentaris Business Overview
11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2018-2023)
11.3.5 AEterna Zentaris Recent Development
11.4 AEterna Zentaris AG
11.4.1 AEterna Zentaris AG Company Detail
11.4.2 AEterna Zentaris AG Business Overview
11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2018-2023)
11.4.5 AEterna Zentaris AG Recent Development
11.5 Eurofins Advinus
11.5.1 Eurofins Advinus Company Detail
11.5.2 Eurofins Advinus Business Overview
11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2018-2023)
11.5.5 Eurofins Advinus Recent Development
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Detail
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2018-2023)
11.6.5 Pieris Pharmaceuticals Recent Development
11.7 Dafra Pharma
11.7.1 Dafra Pharma Company Detail
11.7.2 Dafra Pharma Business Overview
11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2018-2023)
11.7.5 Dafra Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Meglumine Antimoniate
Table 3. Key Players of Pentamidine
Table 4. Key Players of Hydroxyl Amidine Stilbene
Table 5. Key Players of Amphotericin B
Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Leishmaniasis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Leishmaniasis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Leishmaniasis Treatment Market Share by Region (2018-2023)
Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Leishmaniasis Treatment Market Share by Region (2024-2033)
Table 12. Leishmaniasis Treatment Market Trends
Table 13. Leishmaniasis Treatment Market Drivers
Table 14. Leishmaniasis Treatment Market Challenges
Table 15. Leishmaniasis Treatment Market Restraints
Table 16. Global Leishmaniasis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Leishmaniasis Treatment Market Share by Players (2018-2023)
Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2022)
Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Leishmaniasis Treatment Product Solution and Service
Table 23. Date of Enter into Leishmaniasis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Leishmaniasis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Leishmaniasis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Leishmaniasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Leishmaniasis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Leishmaniasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Leishmaniasis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Leishmaniasis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Leishmaniasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Leishmaniasis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Leishmaniasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Leishmaniasis Treatment Product
Table 51. Merck Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 52. Merck Recent Development
Table 53. iCo Therapeutics Company Detail
Table 54. iCo Therapeutics Business Overview
Table 55. iCo Therapeutics Leishmaniasis Treatment Product
Table 56. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 57. iCo Therapeutics Recent Development
Table 58. AEterna Zentaris Company Detail
Table 59. AEterna Zentaris Business Overview
Table 60. AEterna Zentaris Leishmaniasis Treatment Product
Table 61. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 62. AEterna Zentaris Recent Development
Table 63. AEterna Zentaris AG Company Detail
Table 64. AEterna Zentaris AG Business Overview
Table 65. AEterna Zentaris AG Leishmaniasis Treatment Product
Table 66. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 67. AEterna Zentaris AG Recent Development
Table 68. Eurofins Advinus Company Detail
Table 69. Eurofins Advinus Business Overview
Table 70. Eurofins Advinus Leishmaniasis Treatment Product
Table 71. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 72. Eurofins Advinus Recent Development
Table 73. Pieris Pharmaceuticals Company Detail
Table 74. Pieris Pharmaceuticals Business Overview
Table 75. Pieris Pharmaceuticals Leishmaniasis Treatment Product
Table 76. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 77. Pieris Pharmaceuticals Recent Development
Table 78. Dafra Pharma Company Detail
Table 79. Dafra Pharma Business Overview
Table 80. Dafra Pharma Leishmaniasis Treatment Product
Table 81. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2018-2023) & (US$ Million)
Table 82. Dafra Pharma Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leishmaniasis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Leishmaniasis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Meglumine Antimoniate Features
Figure 4. Pentamidine Features
Figure 5. Hydroxyl Amidine Stilbene Features
Figure 6. Amphotericin B Features
Figure 7. Global Leishmaniasis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Leishmaniasis Treatment Market Share by Application: 2022 VS 2033
Figure 9. Visceral Leishmaniasis Case Studies
Figure 10. Cutaneous Leishmaniasis Case Studies
Figure 11. Leishmaniasis Treatment Report Years Considered
Figure 12. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Leishmaniasis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Leishmaniasis Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Leishmaniasis Treatment Market Share by Players in 2022
Figure 16. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2022
Figure 18. North America Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Leishmaniasis Treatment Market Share by Country (2018-2033)
Figure 20. United States Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Leishmaniasis Treatment Market Share by Country (2018-2033)
Figure 24. Germany Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2018-2033)
Figure 32. China Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Leishmaniasis Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 47. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 48. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 49. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 50. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 51. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 52. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed